Assessing The Efficacy of

Cannabis Compositions

Our study with researchers at
the University of Michigan,
LEVEL and Overcome

The focus of this study is to address the gaps in cannabinoid research related to the efficacy of unique product formulations and dosing for specific types of chronic pain. To get accurate dosing measurements all study products are tablets or capsules. 

This is one of the first studies to look at efficacy trends related to dosing combined with unique product formulations.

Fibromyalgia, Rheumatoid Arthritis, and Osteoarthritis are the specific types of chronic pain being studied.

There are upwards of 40 million individuals living with these conditions and even more battling chronic pain. This study is a step in the direction of helping patients and practitioners have a better understanding of how to properly use cannabinoid medicine as a natural and effective therapy.

Study Sponsors

LEVEL is a science-driven cannabis company on the cutting edge of cannabinoid research and innovation that is passionate about helping to guide humans with the information and products they need in order to make informed decisions and take action. We launched LEVEL with one goal in mind: to create unique, targeted effects-based cannabis products by formulating cannabinoids in ratios not accessible from the plant alone.

At Overcome we strive to help you Overcome the next mile! With natural supplements formulated for optimized absorption, targeted recovery and responsive results, Overcome uses patented, organic bioavailability technology, powered by Naturia+, and science-based supplements to empower you to achieve your desired lifestyle. Overcome the obstacles that keep you from achieving peak performance. Initially started with the mission of supporting our co-founder’s journey to overcome Lyme Disease, Overcome donates 1% of sales to Lyme Disease research and education. At Overcome we believe the first step is to say you can! 

Meet the PI

Daniel J. Kruger

Research Investigator, Population Studies Center.

Ph.D., Psychology

Dr. Kruger is interested in community-based prevention research aimed at improving health status and reducing morbidity and mortality among populations experiencing a disproportionate share of poor health outcomes. He studies several areas from an evolutionary perspective and conducts basic research as well as implementing practical applications.

Study Partners

This study wouldn’t be possible without the support of our study partners. We are BetterTogether.

Participant FAQ

Can I participate in the study if I do not have fibromyalgia, OA or RA?

Unfortunately no. This study is only for those who have been diagnosed with fibromyalgia or RA or OA. You can sign up to be notified about research opportunities by clicking here.

Do I have to live in the state of California?

Yes, you need to be a current resident of California.

Do I have to download the Releaf App to participate?

It is preferred that you use Releaf App during your participation in the study, but it is not required. Using Releaf App will give us another level of insight on the use and efficacy of the study products, which will help advance the quality of the study. Plus, Releaf App is awesome! So why wouldn’t you want to use it 🙂

Do I have to pay for the study product?

To comply with California state law participants will have to pay $15 in exchange for their 12-week supply of study product. Which equals several hundreds of dollars worth of product.

Are study participants compensated?

Participants who complete the study may receive $50 – $500 in Amazon gift cards. Not all participants will receive a gift card. Participants who answer all study questions will be selected at random. More info at releaf.at/umpain.

How long is the study for?

Each participant will be in the study for 12-weeks.

How will the products be sent to me?

Depending on the study product, it will be delivered right to your door via USPS shipping or by our awesome study partner FLOWER CO.

Will I know the results of the study?

Yes, we will share the results after all participants complete the study. The Principal Investigator at the University of Michigan will take the results to submit for publication and we will share additional reports as well. Just be patient with us. It will take some time to analyze the results and have findings to share.

How much do the products cost after the study?

These prices are the current prices at the time this page went live. We do not guarantee that these will be the same prices after the study.

Overcome Relief: $49.99

LEVEL Protab 1:1: $32.50 (depending on tax)

LEVEL Recover: $32.50 (depending on tax)

Who is MoreBetter?

We are the creators of Releaf App. We are a software, data, and research company that developed patented and patent-pending technology collecting real-world evidence data on the use, performance, and safety of specific products. Our mission is to help individuals make better purchasing, consumption, and treatment decisions with data, not reviews.

Why is Releaf App involved in this study?

It is part of our continued effort to advance cannabinoid research. We currently have 9 retrospective publications. With the University of Michigan we want to contribute to the gap in data related to specific types of pain, product formulation, administration form, and dosing.

Why is University of Michigan involved in this study?

They are the Principal Investigators. They are designing and leading this study.

How will the study questions be administered?

Using MoreBetter technologies text messages will be sent to participant’s phone when it’s time to answer study questions.

Will I need to travel to a facility to answer study questions?

Nope. You get to participate in this study from the comfort and safety of your home.

What if I am running low on my study product?

There are instructions built into the study to guide you along the reordering process if you are low on study product.

What if I experience an adverse event during the study?

There are instructions built into the study that will guide you through connecting with the Principal Investigator regarding your adverse event.

Enroll in the study today!

Pin It on Pinterest